RA Capital Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Sell |
1,039,295
-2,360,705
| -69% | -$7.15M | 0.05% | 60 |
|
|
2025
Q1 | $14.5M | Hold |
3,400,000
| – | – | 0.24% | 58 |
|
|
2024
Q4 | $18M | Buy |
3,400,000
+1,500,000
| +79% | +$7.92M | 0.24% | 60 |
|
|
2024
Q3 | $3.48M | Hold |
1,900,000
| – | – | 0.04% | 74 |
|
|
2024
Q2 | $3.95M | Buy |
+1,900,000
| New | +$3.95M | 0.05% | 74 |
|
|
2019
Q1 | – | Sell |
-33,437
| Closed | -$3.04M | – | 30 |
|
|
2018
Q4 | $3.04M | Hold |
33,437
| – | – | 0.18% | 25 |
|
|
2018
Q3 | $2.61M | Hold |
33,437
| – | – | 0.14% | 26 |
|
|
2018
Q2 | $3.28M | Hold |
33,437
| – | – | 0.21% | 26 |
|
|
2018
Q1 | $3.34M | Hold |
33,437
| – | – | 0.26% | 28 |
|
|
2017
Q4 | $2.54M | Hold |
33,437
| – | – | 0.21% | 25 |
|
|
2017
Q3 | $2.68M | Hold |
33,437
| – | – | 0.24% | 27 |
|
|
2017
Q2 | $2.04M | Buy |
+33,437
| New | +$2.04M | 0.23% | 22 |
|
|
2016
Q4 | – | Sell |
-40,673
| Closed | -$15.2M | – | 34 |
|
|
2016
Q3 | $15.2M | Hold |
40,673
| – | – | 1.57% | 15 |
|
|
2016
Q2 | $13.1M | Hold |
40,673
| – | – | 1.81% | 14 |
|
|
2016
Q1 | $12.6M | Buy |
40,673
+3,750
| +10% | +$1.16M | 1.61% | 20 |
|
|
2015
Q4 | $22.9M | Sell |
36,923
-749
| -2% | -$465K | 2.27% | 15 |
|
|
2015
Q3 | $21M | Hold |
37,672
| – | – | 3.01% | 11 |
|
|
2015
Q2 | $26.9M | Buy |
37,672
+6,422
| +21% | +$4.59M | 2.71% | 12 |
|
|
2015
Q1 | $14.5M | Hold |
31,250
| – | – | 1.44% | 19 |
|
|
2014
Q4 | $13M | Buy |
+31,250
| New | +$13M | 1.4% | 19 |
|